Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

The Blood-brain Barrier

The Blood-brain Barrier

Neurogenesis and Regeneration of Nervous Tissue

Neurogenesis and Regeneration of Nervous Tissue

In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...

Neuroplasticity

Neuroplasticity

Neuroplasticity reflects the brain's remarkable capacity to adapt and evolve, responding dynamically to learning, experiences, or injury by reorganizing its neural circuitry. This reorganization involves creating new neural connections and refining old ones through a series of biological processes that contribute to the brain's lifelong development and adaptability.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Current treatment strategies for vitreomacular traction and macular holes: a survey of retinal specialists in Germany].

Die Ophthalmologie·2024

Same author

[Tonometry and pachymetry to evaluate fluctuations of intraocular pressure in the context of SCUBA diving].

Die Ophthalmologie·2023

Same author

The use of HCT and/or ACE inhibitors significantly increases the risk of non-melanotic skin cancer in the periocular region.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2022

Same author

[Erratum to: Optical coherence tomography biomarkers in epimacular membranes and vitreomacular traction syndrome].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2021

Same author

[Optical coherence tomography biomarkers in epimacular membranes and vitreomacular traction syndrome].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2021

Same author

[Biomarkers in full-thickness and lamellar defects of the macula].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2021

Same journal

["DOG 2020 online" - for the first time in the von Graefe year].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2024

Same journal

[Are organ and co-cultures an alternative to animal models in ophthalmology?]

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2022

Same journal

[Pediatric corneal opacities : Even small improvements provide lifelong help].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2022

Same journal

[Myxoma of the conjunctiva].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2022

Same journal

[Secondary open-angle glaucoma: uveitic secondary glaucoma, steroid-induced glaucoma, posttraumatic and postoperative glaucoma, tumor-related glaucoma and glaucoma due to elevated episcleral venous pressure].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2022

Same journal

[Artificial intelligence in the management of anti-VEGF treatment: the Vienna fluid monitor in clinical practice].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2022

See all related articles

Search research articles

Related Experiment Video

Updated: May 7, 2026

Strategies for Study of Neuroprotection from Cold-preconditioning

Strategies for Study of Neuroprotection from Cold-preconditioning

Published on: September 2, 2010

[Neuroprotective approaches].

S Thaler¹, C Haritoglou, F Schuettauf

¹Department für Augenheilkunde, Eberhard-Karls-Universität, Schleichstr. 12-16, 72076, Tübingen, Deutschland, sebastian.thaler@uni-tuebingen.de.

Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft

|September 19, 2013

Summary

This summary is machine-generated.

Vitreoretinal surgery safety is improving with neuroprotective agents like taurine. Further research is needed to evaluate their clinical use and prevent neurodegeneration during surgery.

More Related Videos

Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia

Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia

Published on: July 31, 2017

Related Experiment Videos

Last Updated: May 7, 2026

Strategies for Study of Neuroprotection from Cold-preconditioning

Strategies for Study of Neuroprotection from Cold-preconditioning

Published on: September 2, 2010

Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia

Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia

Published on: July 31, 2017

Area of Science:

Ophthalmology
Neuroscience
Pharmacology

Context:

Vitreoretinal surgery has evolved over 40 years to minimize toxic effects.
Recent advancements focus on pharmacological interventions to prevent neurodegeneration.
Taurine is an example of a neuroprotectant being explored for irrigating solutions.

Purpose:

To provide an overview of current neuroprotective strategies for vitreoretinal surgery.
To critically analyze the clinical relevance of these neuroprotective agents.
To highlight the potential of various neuroprotective substances based on experimental data.

Summary:

Vitreoretinal surgery has seen continuous improvements to reduce toxicity.
Neuroprotection via pharmacological agents is a recent focus, with taurine as an example.
While few agents are in clinical use, experimental data show high potential for neuroprotective substances.

Impact:

Advances in neuroprotection can enhance patient outcomes in vitreoretinal surgery.
Increased clinical evaluation of neuroprotective agents is necessary for broader adoption.
This review aids in understanding the current landscape and future potential of neuroprotection in ophthalmic surgery.